It is developing ground-breaking medicines in oncology and other fields with a portfolio of commercialized medications that includes EPKINLY, TEPKINLY, and Tivdak, as well as a strong pipeline ...

Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Creating a strong brand identity ...

“In clinical trials, TIVDAK demonstrated a superior overall survival benefit ... The study was conducted by Seagen, which was acquired by Pfizer in December 2023, in collaboration with Genmab, ...

COPENHAGEN, Denmark I March 31, 2025 I Genmab A/S (Nasdaq: GMAB)announced today that the European Commission (EC) has granted marketing authorization for TIVDAK ® (tisotumab ... The study was ...

“In clinical trials, TIVDAK demonstrated a superior overall ... The study was conducted by Seagen, which was acquired by Pfizer in December 2023, in collaboration with Genmab, European Network ...

"In clinical trials, TIVDAK demonstrated a superior overall survival benefit and manageable safety profile compared to chemotherapy, supporting its position to become a potential new standard of ...

"In clinical trials, TIVDAK demonstrated a superior overall survival benefit and manageable safety profile compared to chemotherapy, supporting its position to become a potential new standard of care ...

TIVDAK® is the first and only antibody-drug ... The study was conducted by Seagen, which was acquired by Pfizer in December 2023, in collaboration with Genmab, European Network of Gynaecological ...